Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NSPH

(NSPH) (NSPH) Stock Price, News & Analysis

(NSPH) logo

About (NSPH) Stock (NASDAQ:NSPH)

Advanced Chart

Key Stats

Today's Range
$1.69
$1.69
50-Day Range
N/A
52-Week Range
$0.48
$3.64
Volume
N/A
Average Volume
886,293 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.

Receive NSPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter.

NSPH Stock News Headlines

Only a handful of people know the setup that's defied these chaotic markets.
Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day. That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan. Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout. Naturally, no one can guarantee what the market does in the future… But these simple daily options setups have paid out with the market rallying, dropping, or staying flat. And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself…
See More Headlines

NSPH Stock Analysis - Frequently Asked Questions

(NSPH) (NASDAQ:NSPH) released its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) earnings per share for the quarter, topping the consensus estimate of ($0.59) by $0.04. The firm's revenue was up 43.5% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Meta Platforms (META), Advanced Micro Devices (AMD), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL) and Molecular Templates (MTEM).

Company Calendar

Last Earnings
5/16/2016
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:NSPH
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:NSPH) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners